TELEPERFORMANCE 46.050 € (-6,99 %)
VALLOUREC 20.190 € (+2,88 %)
STMICROELECTRONICS 27.510 € (+1,89 %)
SOCIETE GENERALE 63.520 € (-0,50 %)
BNP PARIBAS ACT.A 82.940 € (-0,49 %)
AKZO NOBEL 48.940 € (+1,33 %)
SCHNEIDER ELECTRIC 241.800 € (-0,62 %)
ADYEN 888.500 € (+1,21 %)
LVMH 460.750 € (-1,25 %)
CARREFOUR 15.330 € (+2,17 %)
WINAMP GROUP 0.496 € (-6,42 %)
EXOR NV 63.500 € (-1,85 %)
ARCELORMITTAL SA 45.230 € (+2,31 %)
LEGRAND 135.500 € (+0,63 %)
SOITEC 50.700 € (-2,20 %)
BE SEMICONDUCTOR 184.100 € (+0,85 %)
TOTALENERGIES 77.210 € (+1,59 %)
SANOFI 77.770 € (+1,22 %)
AHOLD DEL 40.530 € (+1,17 %)
WOLTERS KLUWER 62.560 € (-1,97 %)
ORANGE 17.200 € (+1,42 %)
CREDIT AGRICOLE 16.105 € (-0,46 %)
ING GROEP N.V. 21.775 € (-1,43 %)
ESSILORLUXOTTICA 192.750 € (-0,16 %)
CAPGEMINI 96.360 € (-1,91 %)
VINCI 127.350 € (+0,55 %)
SHELL PLC 39.925 € (+2,90 %)
CATERING INTL SCES 13.300 € (+3,10 %)
TECHNIP ENERGIES 34.100 € (0,00 %)
EXOSENS 61.800 € (-2,06 %)
DSM FIRMENICH AG 58.940 € (+1,41 %)
HEINEKEN HOLDING 60.800 € (-0,33 %)
AXA 37.900 € (+0,08 %)
BUREAU VERITAS 26.000 € (0,00 %)
POUJOULAT 8.000 € (+2,04 %)
SAINT GOBAIN 70.420 € (-0,56 %)
BOLLORE 4.850 € (0,00 %)
ABN AMRO BANK N.V. 26.760 € (-0,41 %)
SAFRAN 282.100 € (-1,81 %)
VOPAK 45.620 € (+0,53 %)
EURONEXT 135.100 € (+1,66 %)
CRCAM NORM.SEINE 131.600 € (-2,79 %)
VIVENDI SE 1.689 € (-0,50 %)
PERNOD RICARD 62.900 € (-1,16 %)
RUBIS 33.280 € (+1,09 %)
SCOR SE 30.120 € (-0,07 %)
ARKEMA 54.300 € (+2,55 %)
NN GROUP 65.620 € (-0,36 %)
ASR NEDERLAND 58.200 € (+0,45 %)
ASML HOLDING 1 201.600 € (+2,23 %)
MOULINVEST 24.000 € (+1,69 %)
CORBION 18.340 € (+1,55 %)
TF1 6.920 € (0,00 %)
HIGH CO 3.490 € (-1,41 %)
UMG 15.465 € (-1,72 %)
WORLDLINE DS 0.560 € (-19,56 %)
BOURSE DIRECT 4.450 € (-1,98 %)
HEINEKEN 65.720 € (-0,03 %)
AALBERTS NV 30.360 € (-0,46 %)
OREGE 0.290 € (-2,68 %) |
16/03/2026 19:50
EQS-Adhoc: Softing AG approves 10% cash capital increase excluding subscription rightsEQS-Ad-hoc: Softing AG / Key word(s): Capital measures / Capital increase NOT FOR DISTRIBUTION, PUBLICATION OR TRANSMISSION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, AUSTRALIA OR JAPAN OR ANY OTHER JURISDICTION WHERE SUCH DISTRIBUTION, PUBLICATION OR TRANSMISSION WOULD BE UNLAWFUL. FURTHER RESTRICTIONS APPLY. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Disclosure of inside information pursuant to Article 17 of Regulation (EU) No 596/2014 Softing AG approves 10% cash capital increase excluding subscription rights Haar, 16. March 2026 – The management board of Softing AG (ISIN: DE0005178008 I WKN: 517800) (“Company”) today resolved, with the approval of the Company’s supervisory board, to increase the Company’s share capital by approximately 10% against cash contributions by issuing 992,588 new no-par value bearer shares of the Company (“New Shares”) by partially utilizing the Authorized Capital 2025/I and excluding shareholders’ subscription rights (“Capital Increase”). Upon registration of the implementation of the Capital Increase with the commercial register, the Company’s share capital will increase from currently EUR 9,925,881.00 by EUR 992,588.00 to EUR 10,918,469.00. The New Shares were subscribed exclusively by Noser Management AG, Zurich, Switzerland (“Noser”), as a major shareholder of the Company, in a private placement at a placement price of EUR 3.20 per New Share. The placement price is 15.94% above the closing price (XETRA) of the Company’s shares on 16 March 2026. Following the Capital Increase, Noser and Rudolf Noser will together hold around 27.68% of the Company’s share capital and voting rights; Noser will be subject to a customary 90‑day lock‑up obligation. The gross proceeds from the Capital Increase amount to approximately EUR 3.2 million. The Company intends to use the net proceeds from the Capital Increase primarily for strengthening of its equity base. After the Capital Increase has been registered with the commercial register, the New Shares will be admitted to trading on the regulated market of the Frankfurt Stock Exchange (Prime Standard) without a prospectus. End of inside information _________________________________________________________________________ IMPORTANT NOTICE: This announcement and the information contained herein are for informational purposes only and do not constitute a prospectus or an offer to sell or a solicitation of an offer to buy any securities of the Company in the United States of America (including its territories and possessions, the states of the United States of America and the District of Columbia) ("United States") or any other jurisdiction. This publication may not be distributed, published or circulated in the United States, Australia, Canada, Japan and other countries where such distribution or publication may be unlawful. The Company’s securities have not been and will not be registered under the U.S. Securities Act of 1933, as amended ("Securities Act"), and may not be offered or sold in the United States absent registration or an applicable exemption from the registration requirements of the Securities Act, or in a transaction not subject to the registration requirements of the Securities Act. or the applicable securities laws of Australia, Canada or Japan. There will be no public offering of shares of the Company. The distribution of this announcement may be restricted by law in certain jurisdictions and persons in possession this announcement or the information referred to herein should inform themselves about and observe any such restrictions. Failure to comply with such restrictions may constitute a violation of the securities laws of such jurisdictions. Contact: Dr. Wolfgang Trier CEO End of Inside Information 16-March-2026 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
2292234 16-March-2026 CET/CEST Source : Webdisclosure.com |
||||||||||||||||||||||||||||||||
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière